Your browser doesn't support javascript.
loading
A systematic review of posterior reversible encephalopathy syndrome in pregnant women with severe preeclampsia and eclampsia.
Tawati, Dalal A; Chan, Wee-Shian.
Afiliação
  • Tawati DA; Department of Obstetrics and Gynecology, University of British Columbia, Maternal Fetal Medicine Subspecialty Program, Children's & Women's Hospital, Vancouver, BC, Canada.
  • Chan WS; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Obstet Med ; 16(4): 236-241, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38074208
Background: The association of posterior reversible encephalopathy syndrome (PRES) and severe preeclampsia/eclampsia has been established but the frequency is uncertain. Objectives: To determine the frequency of PRES in severe preeclampsia or eclampsia. Methods: We searched published articles in PubMed, Cochrane library, Embase, and CINAHL from 1990 to 2020. We included articles that reported on six or more cases of PRES with eclampsia or severe preeclampsia who underwent neuroimaging during pregnancy or up to 6 weeks postpartum. Results: We identified 29 studies presenting data on 1519 women with eclampsia or severe preeclampsia. Among 342 women with eclampsia who had neuroimaging, 176 (51.4%) were diagnosed with PRES. Of 121 women with severe preeclampsia, 24 (19.8%) had PRES. The pooled maternal death rate was 5.3% (21/395). Conclusion: PRES is commonly reported on neuroimaging of women with eclampsia/ severe preeclampsia. The role of neuroimaging in eclampsia and especially in women with severe preeclampsia requires re-evaluation as further management is often dictated by this finding.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article